Medical specialists from Canada tagged as investigators in clinical trials studying Neoplasm Metastasis
Total 140 results
-
Abhirami Hallock, FRCPCSeen in:
- Ontario, St. Catharines, Niagra Health System
Trials:- NCT03721341 (Principal Investigator)
Conditions: -
Adrian Sacher, MDSeen in:
- Ontario, Toronto, Princess Margaret Cancer Centre
Trials:- NCT04563338 (Principal Investigator)
-
Aisling Barry, MRCPI,FFRRCSISeen in:
- Ontario, Toronto, University Health Network
Trials:- NCT03721341 (Principal Investigator)
Conditions: -
Aklile WorknehSeen in:
- Ontario, Ottawa, The Ottawa Hospital
Trials:- NCT04272931 (Sub-Investigator)
- NCT05428735 (Sub-Investigator)
-
Alan M. NicholSeen in:
- British Columbia, Vancouver, BCCA-Vancouver Cancer Centre
Trials:- NCT03550391 (Principal Investigator)
- NCT03488693 (Principal Investigator)
Conditions: -
Alan Nichol, MDSeen in:
- British Columbia, Vancouver, BC Cancer - Vancouver
Trials:- NCT05050929 (Principal Investigator)
Conditions: -
Amit OzaSeen in:
- Ontario, Toronto, Princess Margaret Cancer Centre - University Health Network
- Ontario, Toronto, Princess Margaret Hospital
- Ontario, Toronto, University Health Network - Princess Margaret Hospital
- Ontario, Toronto, University health Network (UHN)-University of Toronto
Trials:- NCT05483933 (Principal Investigator)
- NCT04260802 (Principal Investigator)
- NCT05041257 (Principal Investigator)
- NCT02632448 (Principal Investigator)
Conditions:- Ovarian Cancer;
- Fallopian Tube Cancer;
- Epithelial Ovarian Cancer;
- Platinum-resistant Ovarian Cancer;
- Primary Peritoneal Carcinoma;
- Platinum-Resistant Fallopian Tube Carcinoma;
- Platinum-Resistant Primary Peritoneal Carcinoma;
- Sarcoma;
- Neoplasms;
- Renal Cell Carcinoma;
- Cervical Cancer;
- Cancer;
- Hepatocellular Carcinoma;
- Gastric Cancer;
- Non Small Cell Lung Cancer;
- Metastatic Cancer;
- Squamous Cell Carcinoma of Head and Neck;
- Bladder Cancer;
- Triple Negative Breast Cancer;
- Urothelial Carcinoma;
- Merkel Cell Carcinoma;
- Squamous Cell Carcinoma;
- Locally Advanced Malignant Neoplasm;
- Locally Advanced Solid Tumor;
- Urothelial Neoplasm;
- Peritoneal Cancer;
- Soft Tissue Sarcoma;
- Breast Cancer;
- Colorectal Cancer;
- Pancreatic Cancer;
- Rectal Cancer;
- Endometrial Cancer;
- Colon Cancer;
- Solid Tumors;
- Pancreas Cancer
-
Andrew PearceSeen in:
- Ontario, Sudbury, Health Sciences North
Trials:- NCT03721341 (Principal Investigator)
Conditions: -
Anne-Julie SimardSeen in:
- Quebec, Quebec City, CHU de Québec
Trials:- NCT06349278 (Sub-Investigator)
Conditions: -
Annie Arteau, MDSeen in:
- Quebec, Québec, Hôtel Dieu du Quebec
Trials:- NCT03944798 (Principal Investigator)
Conditions: -
Annie EbacherSeen in:
- Quebec, Sherbrooke, Centre Hospitalier Universitaire de Sherbrooke-Fleurimont
Trials:- NCT03550391 (Principal Investigator)
- NCT05050084 (Principal Investigator)
Conditions: -
Anthony C Whitton, MD FRCPCSeen in:
- Ontario, Hamilton, Juravinski Cancer Centre
Trials:- NCT01353573 (Principal Investigator)
Conditions: -
April RoseSeen in:
- Quebec, Montreal, Jewish General Hospital
Trials:- NCT05288166 (Principal Investigator)
Conditions:- Urogenital Neoplasms;
- Prostatic Neoplasms;
- Neoplasm Metastasis;
- Enzyme Inhibitors;
- Antineoplastic Agents;
- Hormones;
- Physiological Effects of Drugs;
- Antineoplastic Agents, Hormonal;
- Androgens;
- Hormones, Hormone Substitutes, and Hormone Antagonists;
- Abiraterone Acetate;
- Steroid Synthesis Inhibitors;
- Cytochrome P-450;
- Prednisone;
- Prednisolone;
- Cyclin-Dependent Kinase 4;
- Cyclin-Dependent Kinase 6
-
Arjun Saghal, MDSeen in:
- Ontario, Toronto, University of Toronto Odette Cancer Centre - T2 158 Sunnybrook Health Sciences Ccenter
Trials:- NCT02830451 (Principal Investigator)
Conditions: -
Arjun Sahgal, MD FRCPCSeen in:
- Ontario, Toronto, Sunnybrook Odette Cancer Centre
Trials:- NCT03881605 (Sub-Investigator)
-
Bruce Ritchie, MDSeen in:
- Alberta, Edmonton, University of Alberta
Trials:- NCT04354129 (Principal Investigator)
-
Caitlin McGregor, MDSeen in:
- Ontario, Toronto, Sunnybrook Health Sciences Centre
Trials:- NCT02036008 (Sub-Investigator)
Conditions: -
Calvin Law, MDSeen in:
- Ontario, Toronto, Sunnybrook Health Sciences Centre
Trials:- NCT02036008 (Sub-Investigator)
Conditions: -
Carl Daigle, MDSeen in:
- Quebec, Quebec City, CHU de Québec
Trials:- NCT06349278 (Sub-Investigator)
Conditions: -
Charles Cunningham, PhDSeen in:
- Ontario, Toronto, Sunnybrook Health Sciences Centre
Trials:- NCT02648009 (Principal Investigator)
- NCT03324360 (Principal Investigator)
Conditions: -
Charles G. Fisher, MDSeen in:
- British Columbia, Vancouver, Vancouver General Hospital and the University of British Columbia
Trials:- NCT02830451 (Principal Investigator)
Conditions: -
Chia-Lin (Eric) Tseng, MDSeen in:
- Ontario, Toronto, Sunnybrook Odette Cancer Centre
Trials:- NCT03775330 (Principal Investigator)
Conditions: -
Cindy Boulanger-Gobeil, MDSeen in:
- Quebec, Quebec City, CHU de Québec
Trials:- NCT05623787 (Sub-Investigator)
- NCT05687617 (Sub-Investigator)
-
Danh Tran-Thanh, MD,MSc,FRCPCSeen in:
- Quebec, Montreal, Centre Hospitalier de l'Université de Montréal
Trials:- NCT04671511 (Sub-Investigator)
-
Daniel J KhalafSeen in:
- British Columbia, Vancouver, BC Cancer Vancouver
Trials:- NCT05288166 (Principal Investigator)
Conditions:- Urogenital Neoplasms;
- Prostatic Neoplasms;
- Neoplasm Metastasis;
- Enzyme Inhibitors;
- Antineoplastic Agents;
- Hormones;
- Physiological Effects of Drugs;
- Antineoplastic Agents, Hormonal;
- Androgens;
- Hormones, Hormone Substitutes, and Hormone Antagonists;
- Abiraterone Acetate;
- Steroid Synthesis Inhibitors;
- Cytochrome P-450;
- Prednisone;
- Prednisolone;
- Cyclin-Dependent Kinase 4;
- Cyclin-Dependent Kinase 6
-
Darin Gopaul, FRCPCSeen in:
- Ontario, Kitchener, Grand River Hospital
Trials:- NCT03721341 (Principal Investigator)
Conditions: -
David AJ Wilson, MD, FRCSCSeen in:
- Nova Scotia, Halifax, Nova Scotia Health
Trials:- NCT03944798 (Principal Investigator)
Conditions: -
David B. ShultzSeen in:
- Ontario, Toronto, University Health Network-Princess Margaret Hospital
Trials:- NCT03550391 (Principal Investigator)
- NCT04114981 (Principal Investigator)
-
David Donath, MDSeen in:
- Quebec, Montréal, Véronique Freire
Trials:- NCT05317026 (Sub-Investigator)
Conditions: -
David Palma, MD, PhDSeen in:
- Ontario, London, London Regional Cancer Program of the Lawson Health Research Institute
Trials:- NCT05717166 (Principal Investigator)
Conditions:
Clinical Trials on Neoplasm Metastasis
-
Betta Pharmaceuticals Co., Ltd.Recruiting
-
BayerCompleted
-
BayerCompletedNeoplasm Metastasis / Bone and BonesBelgium, Spain, Taiwan, United States, Japan, Russian Federation, Canada, Finland, Korea, Republic of, Singapore, Australia, Germany, Israel, United Kingdom, Italy, France, Poland, Brazil, Czechia, Norway, Sweden, Hong Kong
-
National Cancer Institute (NCI)TerminatedCancer | Neoplasm Metastasis | Metastasis | Neoplasm | Radiation OncologyUnited States
-
Cho Ray HospitalUniversity of Medicine and Pharmacy at Ho Chi Minh CityRecruitingSynchronous Neoplasm | Liver Metastasis Colon CancerVietnam
-
MedtronicNeuroCompletedMetastasis Spine | Metastasis to BoneUnited States, Luxembourg, Germany, France, Canada
-
Li MinRecruiting
-
Da FuGanzhou City People's HospitalRecruiting
-
University of Mississippi Medical CenterCompletedMetastasisUnited States
-
Assiut UniversityNot yet recruiting